Edition:
United Kingdom

People: Colgate-Palmolive (India) Ltd (COLG.NS)

COLG.NS on National Stock Exchange of India

1,205.25INR
8:31am BST
Change (% chg)

Rs38.10 (+3.26%)
Prev Close
Rs1,167.15
Open
Rs1,168.00
Day's High
Rs1,221.70
Day's Low
Rs1,153.15
Volume
1,898,094
Avg. Vol
391,903
52-wk High
Rs1,354.80
52-wk Low
Rs1,018.30

Shah, Rajendra 

Shri. Rajendra A. Shah is Non-Executive Independent Vice Chairman of the Board of Colgate Palmolive (India) Limited. He is a Solicitor and a Senior Partner of M/s. Crawford Bayley & Company, a firm of Solicitors and Advocates. He specialises in a broad spectrum of corporate laws in general with special focus on foreign investments, joint ventures, technology & licence agreements, mergers and acquisitions etc. Mr. Shah does not hold any shares in the Company. Mr. Shah is a Director and Member of Board’s Committee of the following other companies : Chairman of : Procter & Gamble Hygiene and Healthcare Ltd., Clariant Chemicals (India) Ltd., Godfrey Phillips India Ltd., Pfizer Ltd. Director of : Abbott India Ltd., Asian Paints Ltd., ACC Ltd., The Bombay Dyeing & Mfg. Co. Ltd., BASF India Ltd., Deepak Fertilisers & Petrochemicals Corporation Ltd., Century Enka Ltd., Jumbo World Holdings Ltd., Lupin Ltd., Wockhardt Ltd., Roche Scientific Co. (I) Pvt. Ltd. and PHL Capital Pvt. Ltd. Alternate Director of : Atul Ltd., Modicare Ltd., RPG Life Sciences Ltd., Schrader Duncan Ltd., and Uhde India Private Ltd. Committee Memberships : Chairman of the Audit Committee of the Boards of : Pfizer Ltd., Procter & Gamble Hygiene & Healthcare Ltd. and Clariant Chemicals (India) Ltd. Member of Audit Committee of : The Bombay Dyeing & Mfg. Co. Ltd., BASF India Ltd., Abbott India Ltd., Century Enka Ltd. and Wockhardt Ltd. Chairman of the Remuneration Committee of : Century Enka Ltd. Member of the Remuneration Committee of : The Bombay Dyeing & Mfg. Co. Ltd., and Lupin Ltd.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --